Cargando…

ECG Changes during Adult Life in Fabry Disease: Results from a Large Longitudinal Cohort Study

Background: Fabry disease (FD) is an X-linked, lysosomal storage disorder leading to severe cardiomyopathy in a significant proportion of patients. To identify ECG markers that reflect early cardiac involvement and disease progression, we conducted a long term retrospective study in a large cohort o...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Sayed, Mohamed, Postema, Pieter G., Datema, Mareen, van Dussen, Laura, Kors, Jan A., ter Haar, Cato C., Bleijendaal, Hidde, Galenkamp, Henrike, van den Born, Bert-Jan H., Hollak, Carla E. M., Langeveld, Mirjam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913957/ https://www.ncbi.nlm.nih.gov/pubmed/36766461 http://dx.doi.org/10.3390/diagnostics13030354

Ejemplares similares

Influence of sex and phenotype on cardiac outcomes in patients with Fabry disease
por: El Sayed, Mohamed, et al.
Publicado: (2021)

Prevalence of ECGs Exceeding Thresholds for ST‐Segment–Elevation Myocardial Infarction in Apparently Healthy Individuals: The Role of Ethnicity
por: ter Haar, C. Cato, et al.
Publicado: (2020)

Developments in the treatment of Fabry disease
por: van der Veen, Sanne J., et al.
Publicado: (2020)

Do sex differences in the prevalence of ECG abnormalities vary across ethnic groups living in the Netherlands? A cross-sectional analysis of the population-based HELIUS study
por: Bolijn, Renee, et al.
Publicado: (2020)

Association between the reflection magnitude and blood pressure in a multiethnic cohort: the Healthy Life in an Urban Setting study
por: Bouwmeester, Thomas A., et al.
Publicado: (2022)

Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease
por: van der Veen, Sanne J., et al.
Publicado: (2020)

The Mini Mental State Examination does not accurately screen for objective cognitive impairment in Fabry Disease
por: Körver, Simon, et al.
Publicado: (2019)

Cognitive functioning and depressive symptoms in Fabry disease: A follow‐up study
por: Körver, Simon, et al.
Publicado: (2020)

A deep learning approach identifies new ECG features in congenital long QT syndrome
por: Aufiero, Simona, et al.
Publicado: (2022)

Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry disease
por: Körver, Simon, et al.
Publicado: (2019)

Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and pain
por: Körver, Simon, et al.
Publicado: (2020)

Antibodies against recombinant enzyme in the treatment of Fabry disease: Now you see them, now you don’t
por: van der Veen, Sanne Jolien, et al.
Publicado: (2022)

Noninvasive tests for nonalcoholic fatty liver disease in a multi‐ethnic population: The HELIUS study
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2022)

Physical Activity and Dietary Composition Relate to Differences in Gut Microbial Patterns in a Multi-Ethnic Cohort—The HELIUS Study
por: Houttu, Veera, et al.
Publicado: (2021)

Poikilothermia in a 38-year-old Fabry patient
por: Biegstraaten, Marieke, et al.
Publicado: (2010)

Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease
por: van Dussen, Laura, et al.
Publicado: (2014)

Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications
por: van Dussen, Laura, et al.
Publicado: (2014)

Quality of life in patients with Fabry disease: a systematic review of the literature
por: Arends, Maarten, et al.
Publicado: (2015)

Cost-effectiveness of enzyme replacement therapy for Fabry disease
por: Rombach, Saskia M, et al.
Publicado: (2013)

Pain management strategies for neuropathic pain in Fabry disease - a systematic review
por: Schuller, Y., et al.
Publicado: (2016)

B-PO05-137 ARRHYTHMIC BURDEN AND THEIR PROGNOSTIC EFFECT ON MORTALITY IN HOSPITALIZED COVID-19 PATIENTS
por: Offerhaus, Joost, et al.
Publicado: (2021)

Determinants of suboptimal blood pressure control in a multi‐ethnic population: The Healthy Life in an Urban Setting (HELIUS) study
por: van der Linden, Eva L., et al.
Publicado: (2021)

Gut microbiome transitions across generations in different ethnicities in an urban setting—the HELIUS study
por: van der Vossen, Eduard W. J., et al.
Publicado: (2023)

Erratum to: Pain management strategies for neuropathic pain in Fabry disease - a systematic review
por: Schuller, Y., et al.
Publicado: (2016)

ECG, LVH and T1 changes in Fabry disease - implications for screening and understanding of the disease model
por: Kozor, Rebecca, et al.
Publicado: (2016)

Inherited metabolic disorders in adults: systematic review on patient characteristics and diagnostic yield of broad sequencing techniques (exome and genome sequencing)
por: Ferreira, Elise A., et al.
Publicado: (2023)

Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review
por: van der Ree, Martijn H, et al.
Publicado: (2022)

To what extent do socioeconomic inequalities in SRH reflect inequalities in burden of disease? The HELIUS study
por: Galenkamp, Henrike, et al.
Publicado: (2019)

Cardiovascular Risk Estimation Based on Country-of-Birth- and Country-of-Residence-Specific Scores among Migrants in the Netherlands: The HELIUS Study
por: Osei-Yeboah, James, et al.
Publicado: (2023)

Renal involvement in a patient with the chronic visceral subtype of acid sphingomyelinase deficiency resembles Fabry disease
por: Eskes, Eline C. B., et al.
Publicado: (2021)

Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests
por: Biegstraaten, Marieke, et al.
Publicado: (2010)

Bone health in patients with inborn errors of metabolism
por: Langeveld, M., et al.
Publicado: (2018)

FHL2 Genetic Polymorphisms and Pro-Diabetogenic Lipid Profile in the Multiethnic HELIUS Cohort
por: Habibe, Jayron J., et al.
Publicado: (2023)

Ethnic Differences in Coronavirus Disease 2019 Hospitalization and Hospital Outcomes in a Multiethnic Population in the Netherlands
por: Collard, Didier, et al.
Publicado: (2022)

Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease
por: Shu, Liming, et al.
Publicado: (2014)

Ethnic differences in urinary monocyte chemoattractant protein-1 and heparanase-1 levels in individuals with type 2 diabetes: the HELIUS study
por: van der Velden, Anouk I M, et al.
Publicado: (2022)

Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation
por: van Kuilenburg, André B. P., et al.
Publicado: (2023)

Prevalence of symptoms in female Fabry disease patients: a case-control survey
por: Bouwman, Machtelt G., et al.
Publicado: (2012)

Manual QT interval measurement with a smartphone-operated single-lead ECG versus 12-lead ECG: a within-patient diagnostic validation study in primary care
por: Beers, Lisa, et al.
Publicado: (2021)

Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain
por: Rombach, Saskia M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lrhn52gde1rj362sqlv1oknn86